Evolent Health filed on Tuesday with the SEC to raise up to $100 million in an initial public offering, and list on the NYSE under the symbol EVH.

Founded in 2011, the Arlington, VA-based company has booked $101 million in sales for the fiscal year ended December 31, 2014. J.P. Morgan and Goldman Sachs are the joint bookrunners on the deal. No pricing terms were disclosed.

Evolent offers health care providers a software platform that manages a value-based care model. Its solutions portfolio includes Strategy & Performance Consulting, Population Health Technology, Value-Based Care Capabilities, and Market-Facing Solutions.

In 2013, the company has secured $100 million in Series B financing from The Advisory Board Company, UPMC Health Plan, and TPG Growth.

[Via: nasdaq]